Deng Y - Search Results

1

LncRNA ENSG00000254615 Modulates Proliferation and 5-FU Resistance by Regulating p21 and Cyclin D1 in Colorectal Cancer.

Fu Y, Huang R, Li J, Xie X, Deng Y. Fu Y, et al. Among authors: deng y. Cancer Invest. 2021 Oct;39(9):696-710. doi: 10.1080/07357907.2021.1923727. Epub 2021 Sep 1. Cancer Invest. 2021. PMID: 33938344

2

[The effect of non-surgical periodontal therapy on blood sugar level of non-insulin dependent diabetes mellitus diabetics with periodontitis].

Fu Y, Ling J, Deng Y. Fu Y, et al. Among authors: deng y. Zhonghua Kou Qiang Yi Xue Za Zhi. 2000 Nov;35(6):444-6. Zhonghua Kou Qiang Yi Xue Za Zhi. 2000. PMID: 11780530 Chinese.

3

Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells.

Deng Y, Su Q, Mo J, Fu X, Zhang Y, Lin EH. Deng Y, et al. Cancer Invest. 2013 Feb;31(2):97-102. doi: 10.3109/07357907.2012.754458. Epub 2012 Dec 17. Cancer Invest. 2013. PMID: 23245395

4

Multi-microarray identifies lower AQP9 expression in adjuvant chemotherapy nonresponders with stage III colorectal cancer.

Dou R, Deng Y, Huang L, Fu S, Tan S, Wang L, Lian L, Fang L, Fan X, Jin G, Liu H, Wang J. Dou R, et al. Among authors: deng y. Cancer Lett. 2013 Aug 9;336(1):106-13. doi: 10.1016/j.canlet.2013.04.017. Epub 2013 Apr 21. Cancer Lett. 2013. PMID: 23612070

5

Circadian Clock Gene CRY2 Degradation Is Involved in Chemoresistance of Colorectal Cancer.

Fang L, Yang Z, Zhou J, Tung JY, Hsiao CD, Wang L, Deng Y, Wang P, Wang J, Lee MH. Fang L, et al. Among authors: deng y. Mol Cancer Ther. 2015 Jun;14(6):1476-87. doi: 10.1158/1535-7163.MCT-15-0030. Epub 2015 Apr 8. Mol Cancer Ther. 2015. PMID: 25855785 Free PMC article.

6

Increased urothelial cancer associated 1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer.

Ni B, Yu X, Guo X, Fan X, Yang Z, Wu P, Yuan Z, Deng Y, Wang J, Chen D, Wang L. Ni B, et al. Among authors: deng y. Int J Oncol. 2015 Oct;47(4):1329-38. doi: 10.3892/ijo.2015.3109. Epub 2015 Jul 29. Int J Oncol. 2015. PMID: 26238511

7

High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment.

Deng Y, Cai Y, Huang Y, Yang Z, Bai Y, Liu Y, Deng X, Wang J. Deng Y, et al. Among authors: deng x. BMC Cancer. 2015 Nov 2;15:833. doi: 10.1186/s12885-015-1840-6. BMC Cancer. 2015. PMID: 26525741 Free PMC article.

8

AQP9-induced cell cycle arrest is associated with RAS activation and improves chemotherapy treatment efficacy in colorectal cancer.

Huang D, Feng X, Liu Y, Deng Y, Chen H, Chen D, Fang L, Cai Y, Liu H, Wang L, Wang J, Yang Z. Huang D, et al. Among authors: deng y. Cell Death Dis. 2017 Jun 22;8(6):e2894. doi: 10.1038/cddis.2017.282. Cell Death Dis. 2017. PMID: 28640255 Free PMC article.

9

[Choice of neoadjuvant therapy for rectal cancer: simple chemotherapy or synchronous chemoradiotherapy].

Li J, Deng Y, Wang J. Li J, et al. Among authors: deng y. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Jun 25;21(6):627-631. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 29968236 Chinese.

10

Reduction of circulating lymphocyte count is a predictor of good tumor response after neoadjuvant treatment for rectal cancer.

Wu Z, Zhang J, Cai Y, Deng R, Yang L, Li J, Deng Y. Wu Z, et al. Among authors: deng y, deng r. Medicine (Baltimore). 2018 Sep;97(38):e11435. doi: 10.1097/MD.0000000000011435. Medicine (Baltimore). 2018. PMID: 30235653 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,322 results

Search Page

Filters